Overview
Julien Navarro practices in Paris, France. Mr. Navarro is rated as an Advanced expert by MediFind in the treatment of Asphyxiating Thoracic Dystrophy. His top areas of expertise are Asphyxiating Thoracic Dystrophy, Retinopathy Pigmentary Mental Retardation, X-Linked Congenital Stationary Night Blindness, and Cone-Rod Dystrophy.
His clinical research consists of co-authoring 12 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Asphyxiating Thoracic Dystrophy.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Asphyxiating Thoracic DystrophyMr. Navarro isAdvanced. Learn about Asphyxiating Thoracic Dystrophy.
- Retinopathy Pigmentary Mental Retardation
- X-Linked Congenital Stationary Night Blindness
- Experienced
- Age-Related Macular Degeneration (ARMD)Mr. Navarro isExperienced. Learn about Age-Related Macular Degeneration (ARMD).
- Cone DystrophyMr. Navarro isExperienced. Learn about Cone Dystrophy.
- Cone-Rod DystrophyMr. Navarro isExperienced. Learn about Cone-Rod Dystrophy.
- Late-Onset Retinal DegenerationMr. Navarro isExperienced. Learn about Late-Onset Retinal Degeneration.
- Retinitis PigmentosaMr. Navarro isExperienced. Learn about Retinitis Pigmentosa.
- X-Linked Retinitis Pigmentosa (XLRP)Mr. Navarro isExperienced. Learn about X-Linked Retinitis Pigmentosa (XLRP).